<DOC>
	<DOC>NCT01551498</DOC>
	<brief_summary>This is a study to evaluate the safety, tolerability, and potential effects of Anatabloc dietary supplementation on antithyroid autoantibodies, thyroid structure, and thyroid function in subjects with autoimmune thyroiditis.</brief_summary>
	<brief_title>Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)</brief_title>
	<detailed_description>This is a 5-visit, 12-week, double-blind, randomized, placebo-controlled, parallel-group study.</detailed_description>
	<mesh_term>Thyroiditis</mesh_term>
	<mesh_term>Thyroiditis, Autoimmune</mesh_term>
	<criteria>adults 1870 years of age having positive antibodies against thyroid peroxidase having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis having evidence of endstage thyroiditis being a current smoker or smokeless tobacco user be taking systemic glucocorticoids, interferonalpha, antiCD20 antibody, or antiCTLA4 antibody be taking any medication for treatment of autoimmune thyroiditis other than Lthyroxine or equivalent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Hashimoto Disease</keyword>
	<keyword>Thyroiditis</keyword>
</DOC>